Thomas A. Murray - Concepedia

Author

Thomas A. Murray

Also Known As

Daniel D. Murray, Liebovitz, David M., Murray, Thomas A., Neeta Bhat, Saveraid H, Shweta Sharma Mistry, Sue Meger, T Murray, T. Murray, T.A. Murray

118

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center UnitedHealth Group (United States)Hennepin County Medical Center Olive View-UCLA Medical Center

About

Thomas A. Murray is an author at University of Minnesota specializing in medicine, public health, and statistics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Public Health	6	7	828
3	Engineering	2	2	42
4	Health Sciences	2	2	52
5	Management	1	1	26

Thomas A. Murray

Publications

Citations

H-Index

Page 1

	Year	Citations
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial Demetris Yannopoulos, Jason A. Bartos, Ganesh Raveendran, The Lancet Cardiopulmonary ResuscitationCardiovascular DiseaseMedicinePatient SafetyAdvanced Reperfusion Strategies	2020	969
Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis Robert N. Foley, David T. Gilbertson, Thomas A. Murray, New England Journal of Medicine	2011	438
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 Carolyn T. Bramante, Jared D. Huling, Christopher J. Tignanelli, New England Journal of Medicine	2022	235
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray, The Lancet Healthy Longevity Disease Risk AssessmentGlobal HealthCovid-19 PandemicRiskHospital Epidemiology	2020	222
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial Carolyn T. Bramante, John B. Buse, David Liebovitz, The Lancet Infectious Diseases Disease ManagementTreatment And PreventionPost-covid-19 ConditionCovid-19 PandemicClinical Epidemiology	2023	209
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial Thomas L Holland, Adit A. Ginde, Roger Paredes, The Lancet Respiratory Medicine Covid-19 PandemicAntiviral TherapyClinical TrialsCovid-19 EpidemiologyMedicine	2022	124
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 Carolyn T. Bramante, Nicholas E. Ingraham, Thomas A. Murray, Covid-19 EpidemiologyMetformin GroupCovid-19ObesityMetabolic Syndrome	2020	112
A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19 Michael A. Puskarich, Nathan W. Cummins, Nicholas E. Ingraham, EClinicalMedicine	2021	66
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes Thomas A. Murray, Ying Yuan, Peter F. Thall Journal of the American Statistical Association	2017	63
Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury Michael A. Puskarich, Nicholas E. Ingraham, Lisa H. Merck, JAMA Network Open	2022	55

Page 1